Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Sales | 0 | 0 | 0 | 1,250 | 0 |
| Gross Profit | N/A | N/A | N/A | 1,250 | N/A |
| Operating Expenses | 20,802 | 24,556 | 14,200 | 11,499 | 17,850 |
| Operating Income | -20,802 | -24,556 | -14,200 | -10,249 | -17,850 |
| Interest Expense | -30 | 8 | 9 | 5 | 771 |
| Other Income | 0 | -23 | -135 | 0 | -28,597 |
| Pre-tax Income | -20,771 | -24,587 | -14,344 | -10,253 | -47,218 |
| Income Tax | 3 | 3 | 2 | 2 | 2 |
| Net Income Continuous | -20,774 | -24,590 | -14,346 | -10,256 | -47,221 |
| Net Income | $-20,774 | $-24,590 | $-14,346 | $-10,256 | $-47,221 |
| EPS Basic Total Ops | -15.02 | -27.03 | -33.63 | -46.25 | -873.27 |
| EPS Basic Continuous Ops | -14.22 | -25.85 | -31.02 | -40.89 | -802.05 |
| EPS Diluted Total Ops | -15.02 | -27.03 | -33.63 | -46.25 | -873.27 |
| EPS Diluted Continuous Ops | -14.22 | -25.85 | -31.02 | -40.89 | -802.05 |
| EPS Diluted Before Non-Recurring Items | -15.02 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-20,685 | $-24,345 | $-14,119 | $-10,110 | $-17,259 |